genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • GEN Protocols
  • Resources
    • Summits
    • Webinars
    • GEN Live
    • eBooks/Perspectives
    • Podcasts
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • – INSIDE –
    PRECISION MEDICINE
Search
  • About GEN
  • Contact GEN
  • Subscribe/Update Preferences
  • Log In
Sign in
Welcome! Log into your account
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
    • Autoimmune Disease Drugs

      Amgen to Acquire ChemoCentryx for $3.7B, Bolstering Autoimmune Portfolio

      Novel Coronavirus (2019-nCoV) Corona virus vaccine vial dose flu shot drug needle syringe medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization
      Antibodies

      Monoclonal Antibody Prevents Malaria in Clinical Trial

      Alzheimers

      Novel Alzheimer’s Therapy without Inflammatory Side Effects

      News

      Muscle Regeneration May Be Boosted by Naturally Occurring Compound

      Bacteriophages infecting bacteria, illustration
      Bacteriophage

      Oral Combination Phage Therapy Targets IBD-Related Gut Bacteria, Spares Helpful Microbes

  • Insights
    • AllTrends for 2020Trends for 2021
      Amyloid plaques in Alzheimer's disease
      Alzheimers

      Questionable Data Jeopardizes Alzheimer’s Amyloid Theory

      Cancer

      Left-Field Lessons in Immunity: Z-Nucleic Acids Stage a Comeback

      Woman with lab coat in technical room with a fermenter
      Antibodies

      Biomanufacturing Parallels the Semiconductor Chip Revolution

      Two scientists in conversation, standing in laboratory
      Bioprocessing

      Altering Vector Genetics Improves Cell-free Protein Synthesis

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      stocks go up
      A-Lists

      Top 25 Biotech Companies of 2022

      coronavirus
      A-Lists

      Seven Biopharma Trends to Watch in 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • GEN Protocols
  • Resources
    • Summits
    • Webinars
    • GEN Live
    • eBooks/Perspectives
    • Podcasts
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • – INSIDE –
    PRECISION MEDICINE
Home Drug Discovery Target Identification Page 2

Target Identification

  • ADME/TOX
  • Antibodies
  • Assay Development
  • Cell-Based Assays
  • Drug Delivery
  • Drug Interactions
  • Drug Repositioning
  • Druggable Genome
  • GPCRs
  • High-Content Analysis
  • High-Content Screening
  • High-Throughput Screening
  • Outsourcing
  • Small Molecules
  • Target Identification
  • Therapeutics
  • Vaccine Development
    Most popular
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Target Identification

    Parkinson’s Disease Drug That Cools “Brains on Fire” Could Enter Human Trials in 2020

    Target Identification

    Anti-Obesity “Biochemical Cigarette” Exploits Body’s Responses to Cold and Smoking

    Fear
    Target Identification

    Fear in Mind: Coping Mechanism Identified in New Brain Region

    Target Identification

    Softening Up Chemo-Resistant Cancer Cells

    The novel molecule IMP-1088 (yellow) blocks human NMT (blue)
    Target Identification

    Common Cold Blocked from Replicating by Novel Drug Molecule

    Target Identification

    Biogen Joins Centre for Therapeutic Target Validation

    Targeting Cancer Cells
    Target Identification

    Targeting Cancer Cells by Focusing on Protein-Protein Interaction

    Alzheimer's disease
    Target Identification

    Protein Identified as Potential Novel Target for Alzheimer’s Disease

    Target Identification

    Function of Candidate Human Obesity Genes Demonstrated in Fruit Flies

    Circulating tumor cell.
    Target Identification

    Intratumoral Bacteria Boost Cancer Cell Survival, Promote Metastasis in Mice

    UW Medicine Microbiology Lab
    Target Identification

    “Anti-Evolution Drugs” Could Offer New Strategy against Antimicrobial Resistance Crisis

    microprotein PIGBOS
    Target Identification

    Microprotein Could Point to New Therapeutic Targets for Diverse Human Diseases

    Target Identification

    Single Cell Type Identified as Neuroblastoma Target

    Target Identification

    Disabling Blood Clotting Protein Prevents Periodontal Disease in Mice

    Novo Nordisk
    Target Identification

    Intervening in Beta Cell-Immune System Dialogue Could Prevent Diabetes, Study Suggests

    123...18Page 2 of 18

    Recently Featured

    Questionable Data Jeopardizes Alzheimer’s Amyloid Theory

    Questionable Data Jeopardizes Alzheimer’s Amyloid Theory

    Amgen to Acquire ChemoCentryx for $3.7B, Bolstering Autoimmune Portfolio

    Amgen to Acquire ChemoCentryx for $3.7B, Bolstering Autoimmune Portfolio

    Novel Alzheimer’s Therapy without Inflammatory Side Effects

    Novel Alzheimer’s Therapy without Inflammatory Side Effects

    Muscle Regeneration May Be Boosted by Naturally Occurring Compound

    Muscle Regeneration May Be Boosted by Naturally Occurring Compound

    Read the Digital Edition

    Explore

    • About GEN
    • Contact GEN
    • GEN Protocols
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Inside Precision Medicine
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2022 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up